7607 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Duogenic Stemcells Corp. engages in the provision of biotechnology and medical care services. It offers closed culture cell system and cell therapy services. The company was founded on March 22, 2018 and is headquartered in Taichung, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
7607 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company